Purified protein for identifying a cancer-associated retinopathy autoantibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 19, 1998
Issued Date -
N/A
app pub date -
Apr 10, 1995
filing date -
Dec 6, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A composition useful in a method for diagnosing cancer-associated retinopathy including the steps of acquiring a purified aliquot of 26 kDa protein, and, utilizing the protein, or a unique fragment thereof, to perform a patient-serum assay to identify in a sample of a patient's serum the presence of autoantibodies to the 26 kDa protein autoantigen.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully